General MedicationsINJECTIONStandard
POTASSIUM ACETATE
POTASSIUM ACETATE
Standard Dose
2MEQ/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview POTASSIUM ACETATE is listed in Drugs@FDA under application 018896 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM ACETATE Form and strength INJECTABLE;INJECTION - 2MEQ/ML Sponsor HOSPIRA Submission history Latest submission status date: 2014-06-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview POTASSIUM ACETATE is listed in Drugs@FDA under application 018896 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM ACETATE Form and strength INJECTABLE;INJECTION - 2MEQ/ML Sponsor HOSPIRA Submission history Latest submission status date: 2014-06-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.